DEBORAH PERKINS: Open Payments
NPI 1053776179 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,038 in 94 payments from 37 companies in 2025. Trend: 2023 $0 · 2024 $1,527 · 2025 $2,038
Food & beverage: $2,038
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $178 |
| ABBVIE INC. | 6 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $135 |
| Novartis Pharmaceuticals Corporation | 5 | $124 |
| AstraZeneca Pharmaceuticals LP | 6 | $120 |
| Merck Sharp & Dohme LLC | 4 | $94 |
| Eisai Inc. | 4 | $89 |
| Incyte Corporation | 5 | $89 |
| Exelixis Inc. | 4 | $80 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $76 |
Products named: DARZALEX, KISQALI, KEYTRUDA, Enhertu, Lenvima, ICLUSIG, CABOMETYX, ENJAYMO.
Industry payments across MO — which companies pay providers there.
